Carmichael Hill & Associates’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-571
Closed -$13.6K – 800
2023
Q1
$13.6K Hold
571
– – 0.01% 505
2022
Q4
$13.3K Hold
571
– – 0.01% 510
2022
Q3
$13K Buy
+571
New +$13.6K 0.01% 527

Other funds holding IBDS

Carmichael Hill & Associates's IBDS Position: Q2 2023 in Review

Carmichael Hill & Associates sold out of iShares iBonds Dec 2027 Term Corporate ETF (IBDS) in Q2 2023, closing a stake of 571 shares — an estimated $13.6K sold.

Carmichael Hill & Associates first reported a position in IBDS in Q3 2022 and held it in 3 quarters. The position peaked at $13.6K in Q1 2023. 183 funds tracked by Wall St. Rank hold IBDS as of Q2 2023.

  • Carmichael Hill & Associates reported no remaining iShares iBonds Dec 2027 Term Corporate ETF position as of Q2 2023 after selling out during the quarter.
  • Carmichael Hill & Associates sold 571 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2023, an estimated $13.6K.
  • Carmichael Hill & Associates first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2022 and held it in 3 quarters.
  • Carmichael Hill & Associates's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $13.6K in Q1 2023.
  • 183 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2023.

Based on Carmichael Hill & Associates's 13F filing for Q2 2023, filed 4 Aug 2023.